β-Carotene and risk of coronary heart disease. A review of observational and intervention studies

Biomedicine and Pharmacotherapy

Volumn 53, Issue 9, 1999, Pages 409-416

  Tavani, A ^a   La Vecchia, C ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Coronary heart disease; Epidemiology; carotene

Indexed keywords

BETA CAROTENE;

ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; DIET SUPPLEMENTATION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; SMOKING;

EID: 0033213077     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(99)80120-6     Document Type: Article

References (58)

1. Allard JP, Royall D, Kurian R, Muggli R, Jeejeebhoy KN. Effects of β-carotene supplementation on liid peroxidation in humans. Am J Clin Nutr 1994; 59: 884.
2. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey SM, Li B. The Linxian trials: Mortality rates by vitamin-mineral intervention group. Am J Clin Nutr 1995; 62 Suppl: 1424.
3. Bobák M, Brunner E, Miller NJ, Skodová Z, Marmot M. Could antioxidants play a role in high rates of coronary heart disease in the Czech Republic? Eur J Clin Nutr 1998; 52: 632.
4. Bobák M, Hense HW, Kark J, Kuch B, Vojtisek P, Sinnreich R, et al. An ecological study of determinants of coronary heart disease rates: A comparison of Czech, Bavarian and Israeli men. Int J Epidemiol 1999; 28: 437.
5. Bolton-Smith C, Woodward M, Tunstall-Pedoe H. The Scottish heart health study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre. Eur J Clin Nutr 1992; 46: 85.
6. Burton GW, Ingold KU. β-Carotene: An unusual type of lipid antioxidant. Science 1984; 224: 569.
7. D'Avanzo B, La Vecchia C, Braga C, Franceschi S, Negri E, Parpinel M. Nutrient intake according to education, smoking and alcohol in Italian women. Nutr Cancer 1997; 28: 46.
8. Gaziano JM. Antioxidant vitamins and coronary artery disease risk. Am J Med 1994; 97 Suppl 3: 18.
9. Gaziano JM, Hennekens CH. The role of β-carotene in the prevention of cardiovascular disease. Ann NY Acad Sci 1993; 691: 148.
10. Gaziano JM, Manson JE, Branch LG, Colditz GA, Willett WC, Buring JE. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 1995; 5: 255.
11. Gaziano JM, Manson JE, Buring JE, Hennekens CH. Dietary antioxidants and cardiovascular disease. Ann NY Acad Sci 1992; 669: 249.
12. Gey KF. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull 1993; 49: 679.
13. Gey KF, Brubacher GB, Stähelin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987; 45: 1368.
14. Gey KF, Moser UK, Jordan P, Stähelin HB, Eichholzer M, Lüdin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: An epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993; 57 Suppl: 787.
15. Gey KF, Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann NY Acad Sci 1989; 570: 268.
16. Gey KF, Stähelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel prospective study. Clin Invest 1993; 71: 3.
17. Halliwell B. Free radicals and vascular disease: How much do we know? Br Med J 1993; 307: 885.
18. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145.
19. Hennekens CH, Buring JE, Peto R. Antioxidant vitamins - Benefits not yet proved. N Engl J Med 1994; 330: 1081.
20. Hennekens CH, Buring JE, Peto R. Antioxidant vitamins, cancer, and cardiovascular disease. (Letter). N Engl J Med 1994; 335: 1067.
21. Hercberg S, Galan P, Preziosi P. Antioxidant vitamins and cardiovascular disease: Dr Jekyll or Mr Hyde? Am J Publ Health 1999; 89: 289.
22. Hercberg S, Preziosi P, Briançon S, Galan P, Triol I, Malvy D, et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: The SU.VI.MAX study-design, methods, and participant characteristics. Supplementation en Vitamines et Mineraux AntioXidants. Control Clin Trial 1998; 19: 336.
23. Jha P, Flather M, Lonn E, Farkouth M, Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123: 860.
24. Kardinaal AFM, Aro A, Kark JD, Riemersma RA, Van't Veer P, Gomez-Aracena J, et al. Association between b-carotene and acute myocardial infarction depends on polyunsaturated fatty acid status. The EURAMIC study. Arterioscler Thromb Vasc Biol 1995; 15: 726.
25. Kardinaal AFM, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L, et al. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC study. Lancet 1993; 342: 1379.
26. Keaney JF, Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT, et al. Dietary antioxidants preserve endotelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA 1993; 90: 11880.
27. Knekt P, Reunanen A, Järvinen R. Seppänen R, Heliövaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139: 1180.
28. Kohlmeier L, Hastings SB. Epidemiologic evidence of a role of carotenoids in cardiovascular disease prevention. Am J Clin Nutr 1995; 62 Suppl: 1370.
29. Kritchevsky SB, Tell GS, Shimakawa T, Dennis B, Li R, Kohlmeier L, et al. Provitamin A carotenoid intake and carotid artery plaques: The atherosclerosis risk in communities study. Am J Clin Nutr 1998; 68: 726.
30. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu J, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 334: 1156.
31. La Vecchia C, Negri E, Franceschi S, Parazzini F, Decarli A. Differences in dietary intake with smoking, alcohol, and education. Nutr Cancer 1992; 17: 297.
32. Manson JE, Gaziano JM, Spelsberg A, Ridker PM, Cook NR, Buring JE, et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Ann Epidemiol 1995; 5: 261.
33. Manson JE, Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, et al. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation 1991; 84: 546.
34. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease. The lipid research clinics coronary primary prevention trial and follow-up study. JAMA 1994; 272: 1439.
35. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, et al. Guide to preventive cardiology for women. Circulation 1999; 99: 2480.
36. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: A review. Int J Epidemiol 1997; 26: 1.
37. Oliver MF. Antioxidant nutrients, atherosclerosis, and coronary heart disease. Br Heart J 1995; 73: 299.
38. Omenn GS. Interpretations of the Linxian vitamin supplement chemoprevention trials. Epidemiology 1999; 9: 1.
39. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150.
40. Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J. Dietary vitamin C and β-carotene and risk of death in middleaged men. The western electric study. Am J Epidemiol 1995; 142: 1269.
41. Pietinen P, Rimm EB, Korhonen P, Hartman AM, Willett WC, Albanes D, et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The α-tocoherol, β-carotene cancer prevention study. Circulation 1996; 94: 2720.
42. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb 1992; 12: 554.
43. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, et al. Randomised trial of β-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: 1715.
44. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991; 337: 1.
45. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450.
46. Ringer TV, DeLoof MJ, Winterrowd GE, Francom SF, Gaylor SK, Ryan JA, et al. β-Carotene's effects on serum lipoproteins and immunologic indices in humans. Am J Clin Nutr 1991; 53: 688.
47. Singh RB, Niaz MA, Ahmad S, Begum R, Agarwal P. Effect of antioxidant rich foods on plasma ascorbic acid, cardiac enzyme and lipid peroxides levels in patients hospitalized with acute myocardial infarction. J Am Diet Assoc 1995; 95: 775.
48. Singh RB, Niaz MA, Rastogi SS, Rastogi S. Usefulness of antioxidant vitamins in suspected acute myocardial infarction. (The Indian experiment of infarct survival-3). Am J Cardiol 1996; 77: 232.
49. Singh RB, Niaz MA, Rastogi S, Sharma JP, Kumar R, Bishnoi I, et al. Plasma level of antioxidant vitamins and oxidative stress in patients with suspected acute myocardial infarction. Acta Cardiol 1994; 49: 441.
50. Steinberg D. Antioxidants and atherosclerosis. A current assessment. Circulation 1991; 84: 1420.
51. Street DA, Comstock GW, Salkeld RM, Schüep W, Klag MJ. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction? Circulation 1994; 90: 1154.
52. Tavani A, Negri E, D'Avanzo B, La Vecchia C. β-Carotene intake an risk of nonfatal acute myocardial infarction in women. Eur J Epidemiol 1997; 13: 631.
53. Todd S, Woodward M, Bolton-Smith C. An investigation of the relationship between antioxidant vitamin intake and coronary heart disease in men and women using logistic regression analysis. J Clin Epidemiol 1995; 48: 307.
54. Torun M, Yardim S, Sargin H, Simsek B. Evaluation of serum beta-carotene levels in patients with cardiovascular diseases. J Clin Pharm Ther 1994; 19: 61.
55. Tribble DL, for the Nutrition Committee. Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and β-carotene. A statement for healthcare professionals from the American Heart Association. Circulation 1999; 99: 591.
56. Virtamo J, Rapola JM, Ripatti S, Heinonen OP, Taylor PR, Albanes D, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Int Med 1998; 158: 668.
57. Von Eggers Doering W. Antioxidant vitamins, cancer, and cardiovascular disease. (Letter). N Engl J Med 1996; 335: 1065.
58. Witztum JL, Reaven PD, Parthasarathy S. Studies on the ability of dietary supplementation with beta-carotene to protect low-density lipoprotein from oxidative modification. Ann NY Acad Sci 1993; 691: 200.